| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0950-3536(11)80013-2 |
| P698 | PubMed publication ID | 1333850 |
| P50 | author | Sten Eirik W Jacobsen | Q38318684 |
| Francis W. Ruscetti | Q111337552 | ||
| P2093 | author name string | Keller JR | |
| Dubois CM | |||
| P2860 | cites work | Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein | Q24296266 |
| The transforming growth factor-beta family | Q29615948 | ||
| Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist | Q33836551 | ||
| Conditions controlling the proliferation of haemopoietic stem cells in vitro | Q34162126 | ||
| Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance | Q36230050 | ||
| Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
| Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action | Q36353485 | ||
| Induction of high-affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones | Q36354587 | ||
| Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines | Q36355192 | ||
| Inhibition of cytokine production by cyclosporin A and transforming growth factor beta | Q36357285 | ||
| Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex | Q36725987 | ||
| In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. | Q36757194 | ||
| The biology of GM-CSF: regulation of production and interaction with its receptor | Q37876216 | ||
| Colony-forming cells with high proliferative potential (HPP-CFC). | Q37926203 | ||
| The architecture of bone marrow cell populations | Q37981144 | ||
| The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells | Q38202008 | ||
| Role of interleukin-1 in hematopoiesis | Q38204522 | ||
| Transforming growth factor beta: possible roles in the regulation of normal and leukemic hematopoietic cell growth | Q38626298 | ||
| Pure human hematopoietic progenitors: direct inhibitory effect of transforming growth factors-beta 1 and -beta 2. | Q41189973 | ||
| Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines | Q41709531 | ||
| Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes | Q41754784 | ||
| Purification and characterization of mouse hematopoietic stem cells | Q42065991 | ||
| Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha | Q44426080 | ||
| Two forms of transforming growth factor-beta are equally potent selective growth inhibitors of early murine hematopoiesis | Q45289344 | ||
| Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation | Q46512138 | ||
| Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β | Q58479946 | ||
| Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells | Q59051592 | ||
| Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells | Q59070558 | ||
| Defective ability to self-renew in vitro of highly purified primitive haematopoietic cells | Q59094169 | ||
| Role of Transforming Growth Factor-?1 in Regulation of Hematopoiesisb | Q64008477 | ||
| Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells | Q67264564 | ||
| Growth Inhibitory Effects of Transforming Growth Factor-β1 in vivo | Q67819641 | ||
| Inhibitor of stem cell proliferation in normal bone marrow | Q67861654 | ||
| Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1 | Q69763276 | ||
| Spatial organisation of CFU-S proliferation regulators in the mouse femur | Q70719124 | ||
| P433 | issue | 3 | |
| P921 | main subject | hemopoiesis | Q919283 |
| P304 | page(s) | 703-721 | |
| P577 | publication date | 1992-07-01 | |
| P1433 | published in | Best Practice and Research: Clinical Haematology | Q15755888 |
| P1476 | title | Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis | |
| P478 | volume | 5 |
| Q33331088 | Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome |
| Q39375902 | Enhancement of bone ingrowth by transforming growth factor-beta |
| Q40417137 | Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3. |
| Q78550629 | Proteolytic degradation of Smad4 in extracts of AML blasts |
| Q34466460 | Somatic stem cell plasticity: current evidence and emerging concepts. |
| Q37660798 | TGF-β1 Gene -509C/T Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis Involving 11,701 Subjects |
| Q70966187 | Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus |
| Q39833993 | Transforming growth factor-beta1 (TGF-beta1) and acetylcholine (ACh) alter nitric oxide (NO) and interleukin-1beta (IL-1beta) secretion in human colon adenocarcinoma cells. |
Search more.